Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies
Usui, N.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861
2019
ISSN/ISBN: 0385-0684 PMID: 31189804 Document Number: 699820
Document emailed within 1 workday
Related Documents
Usui, N. 2017: Hematologic Malignancies/Pediatric Malignancies Acute Leukemia - Current Treatment and Future Perspective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(5): 378-379Murakami, H.; Saitoh, T.; Kasamatsu, T. 2016: Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 539-544
Usui, N. 2011: Hematologic malignancies/ pediatric malignancies-chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 744
Usui, N. 2009: Hematologic malignancies/pediatric malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 742-743
Nagura, E.; Kawashima, K. 1986: Secondary malignancies associated with hematological malignancies following anticancer treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(4 Part 2): 1464-1474
Ezaki, K. 1996: Cytokine therapy for hematological malignancies International Journal of Hematology 65(1): 17-29
Ozawa, K. 2010: Gene therapy for hematological malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 8): 619-622
Resegotti, L. 1993: The therapy of hematological malignancies in the elderly Haematologica 78(3): 141-144
Aderka, D.; Levo, Y. 1986: Interferon therapy in hematological malignancies Harefuah 110(8): 400-405
Wierda, W.G.; Kipps, T.J. 2000: Gene therapy of hematologic malignancies Seminars in Oncology 27(5): 502-511
Terui, Y. 2012: Monoclonal antibody therapy in hematological malignancies Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 217-221
Niscola, P.; de Fabritiis, P.; Cartoni, C.; Romani, C.; Sorrentino, F.; Dentamaro, T.; Piccioni, D.; Scaramucci, L.; Giovannini, M.; Amadori, S.; Mandelli, F. 2006: Home care management of patients affected by hematologic malignancies: a review Haematologica 91(11): 1523-1529
Shimazaki, C.; Inaba, T.; Murakami, S.; Oku, N.; Itoh, K.; Ura, Y.; Nakagawa, M.; Fujita, N. 1990: Effect of combination therapy with carumonam and clindamycin on severe infections in patients with hematologic malignancies Japanese Journal of Antibiotics 43(8): 1402-1406
Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461
Tsai, M-Shane.; Kuo, C-Yuan.; Wang, M-Chung.; Wu, H-Cheng.; Chien, C-Chih.; Liu, J-Wei. 2006: Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies Journal of Microbiology Immunology and Infection 39(2): 150-154
Okamura, S.; Ikematsu, W. 1993: Hematological malignancies with eosinophilia Nihon Rinsho. Japanese Journal of Clinical Medicine 51(3): 800-805
Takeshita, A.; Ohno, R. 2000: New combination therapies in hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(3): 388-394
Baltz, J.K.; Montello, M.J. 1993: Cladribine for the treatment of hematologic malignancies Clinical Pharmacy 12(11): 805
Nara, N. 2002: Molecular diagnosis in hematologic malignancies Rinsho Byori. Japanese Journal of Clinical Pathology 50(4): 331-336
Jha, A. 2013: Spectrum of hematological malignancies and peripheral cytopenias Journal of Nepal Health Research Council 11(25): 273-278